The IFPAC annual meeting on advancing the understanding and control of manufacturing processes using process analytical technology will be held Feb. 11-14, 2018.
The IFPAC annual meeting on advancing the understanding and control of manufacturing processes using process analytical technology (PAT) will be held Feb. 11–14, 2018 in North Bethesda, MD. For more than 30 years, IFPAC has been a platform for sharing innovative ideas and information to help companies improve the way they manufacture quality products while maintaining global competitiveness, note the conference organizers. This year’s lineup of sessions, roundtables, panel discussions, workshops, poster sessions, and an exhibition will have an increased emphasis on advanced manufacturing science in the biotechnology and biopharmaceutical arenas.
Presenters include FDA and global leaders from industry and academia, and this year there is an increased focus on process control and real-time analytics in biopharmaceutical manufacturing with topics such as:
Other sessions will look at quality by design and real-time release, PAT for continuous manufacturing, quality risk management, knowledge and control of materials during continuous manufacturing of solid doses, advanced separation systems, process Raman technology, emerging technologies for product design and delivery, chemometrics, the industrial Internet of Things, excipients, particle characterization, and more.
Source: IFPAC
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.